Blood glucose test strips are thin strips with enzymes that react to blood droplets. These create either a photometric or electrochemical response which is read by a glucose meter. Strips vary by size, chemical makeup, fluid channels, etc. and are typically sold in containers of 50 or 100. A single strip is used for each test, and some brands have preloaded strip storage within their meters. Electrochemical strips are the most popular type, largely due to the extremely small volumes of blood required to measure glucose. These strips function by working with the blood glucose meter to produce an electrical current, which is proportional to the blood glucose concentration. Several different enzymes may be used for transferring electrons from the glucose in the blood to the electrode. Typically, the current can be measured between 5 and 15 seconds.
The U.S. blood glucose test strip market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose test strip market was the personal segment. Personal test strips are used by individuals who use personal meters to perform self-monitoring of blood glucose (SMBG) on a daily basis. The personal test strip market is further segmented by insurance type and comprises the Medicare/Medicaid, managed care and cash sub-segments. CMS competitive bidding had a significant impact on the personal test strip market after substantial reimbursement cuts in July 2013 and July 2016, respectively. Professional test strips are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Meters in the hospital are typically more technologically advanced than meters found in other settings and often involve software systems which analyze data and provide higher accuracy than personal meters. The growing number of individuals living in nursing homes or other long term care facilities who have diabetes will be the primary driver of market growth. However, as assisted living is becoming more popular, patients are opting for their own personal meters. Long term care centers are also starting to enforce ‘one patient-one meter’ policies, shifting the focus away from professional meters and test strips.
'
TABLE OF CONTENTS I
LIST OF FIGURES III
LIST OF CHARTS V
EXECUTIVE SUMMARY 1
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 9
PROCEDURE NUMBERS 10
PROCEDURE CODES INVESTIGATED 10
MARKETS INCLUDED 11
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 INTRODUCTION 26
2.1.1 Types of Diabetes 26
2.1.2 Diabetes Complications 28
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes 30
2.1.4 Signs and Symptoms 31
2.1.5 Diabetes Monitoring 33
2.1.6 Treatment 35
2.1.7 Drug Delivery Systems 36
BLOOD GLUCOSE TEST STRIP MARKET 38
3.1 INTRODUCTION 38
3.2 MARKET OVERVIEW 39
3.3 MARKET ANALYSIS AND FORECAST 43
3.3.1 Total Blood Glucose Test Strip Market 43
3.3.2 Total Personal Blood Glucose Test Strip Market 45
3.3.2.1 Medicare/Medicaid Blood Glucose Test Strip Market 49
3.3.2.2 Managed Care Blood Glucose Test Strip Market 51
3.3.2.3 Cash Blood Glucose Test Strip Market 53
3.3.3 Professional Blood Glucose Test Strip Market 55
3.4 DRIVERS AND LIMITERS 57
3.4.1 Market Drivers 57
3.4.2 Market Limiters 58
3.5 COMPETITIVE MARKET SHARE ANALYSIS 60
ABBREVIATIONS 64
Chart 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 – 2023 3
Chart 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023 3
Chart 3 1: Blood Glucose Test Strip Market by Segment, U.S., 2013 – 2023 41
Chart 3 2: Blood Glucose Test Strip Market Breakdown, U.S., 2016 42
Chart 3 3: Blood Glucose Test Strip Market Breakdown, U.S.,2023 42
Chart 3 4: Total Blood Glucose Test Strip Market, U.S., 2013 – 2023 44
Chart 3 5: Total Personal Blood Glucose Test Strip Market By Segment, U.S., 2013 – 2023 47
Chart 3 6: Total Personal Blood Glucose Test Strip Market Breakdown, U.S., 2016 48
Chart 3 7: Total Personal Blood Glucose Test Strip Market Breakdown, U.S.,2023 48
Chart 3 8: Medicare/Medicaid Blood Glucose Test Strip Market, U.S., 2013 – 2023 50
Chart 3 9: Managed Care Blood Glucose Test Strip Market, U.S., 2013 – 2023 52
Chart 3 10: Cash Blood Glucose Test Strip Market, U.S., 2013 – 2023 54
Chart 3 11: Professional Blood Glucose Test Strip Market, U.S., 2013 – 2023 56
Chart 3 12: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2016 63
Figure 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4
Figure 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (2 of 2) 5
Figure 1 3: Companies Researched in this Report, U.S., 2016 6
Figure 1 4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (1 of 2) 7
Figure 1 5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (2 of 2) 8
Figure 1 6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 – 2016 9
Figure 1 7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 10
Figure 1 8: Procedure Codes Investigated, U.S., 2016 10
Figure 1 9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (1 of 2) 11
Figure 1 10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (2 of 2) 12
Figure 1 11: Key Report Updates 13
Figure 1 12: Version History 13
Figure 2 1: Major Types of Diabetes and Related Pathologies, U.S., 2016 27
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016 31
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016 32
Figure 3 1: Blood Glucose Test Strip Market by Segment, U.S., 2013 – 2023 (US$M) 40
Figure 3 2: Total Blood Glucose Test Strip Market, U.S., 2013 – 2023 43
Figure 3 3: Total Personal Blood Glucose Test Strip Market, U.S., 2013 – 2023 46
Figure 3 4: Medicare/Medicaid Blood Glucose Test Strip Market, U.S., 2013 – 2023 49
Figure 3 5: Managed Care Blood Glucose Test Strip Market, U.S., 2013 – 2023 51
Figure 3 6: Cash Blood Glucose Test Strip Market, U.S., 2013 – 2023 53
Figure 3 7: Professional Blood Glucose Test Strip Market, U.S., 2013 – 2023 55
Figure 3 8: Drivers and Limiters, Blood Glucose Test Strip Market, U.S., 2016 59
Figure 3 9: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2016 62
Sanofi
Novo Nordisk
Eli Lilly
Medtronic
Johnson & Johnson
Becton Dickinson
Abbott
Roche
DexCom
Ascensia
Insulet
Trividia Health
Tandem
Nova Biomedical
Valeritas
